Annovis Bio Announces Positive FDA Notice For Buntanetap Phase 3 Clinical Trial In Parkinson's Disease

/PRNewswire/ -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases,...

Related Keywords

Berwyn ,Pennsylvania ,United States ,Marial Maccecchini ,Nic Johnson ,Hoehn Yahr ,Annovis Bio ,Exchange Commission ,Prnewswire Annovis Bio Inc ,Linkedin ,Twitter ,Annovis Bio Inc ,Russo Partners ,Company Alzheimer ,Participant Global Impression ,Clinical Global Impression ,Annual Report ,Investor Contact ,Biotechnology ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,